Ubiquinol 100 mg

Ubiquinol 100 mg

NOW4.8 (15,009 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 120 servings
Goals
$53.88 $0.44 per serving

Product analysis

77 out of 100

Ubiquinol 100 mg offers focused CoQ10 support for normal cellular energy production and may help some measures of blood-vessel function. Benefits for tiredness are less certain in people who already feel well.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

CoQ10 is clearly identified, but a form-quality advantage has not been established. The name alone does not show better absorption than other CoQ10 preparations.

Ingredient Transparency100

The CoQ10 amount and form are both stated. That makes the single active straightforward to compare with alternatives.

Value For Money100

The CoQ10 serving offers favorable value for its declared content. The price comparison does not establish an absorption advantage.

Customer Satisfaction94

Customers give consistently favorable ratings across a large review base. The volume makes the satisfaction picture more established, without proving health benefits.

Product Focus73

A single active keeps the formula focused on CoQ10-related support. Its strongest connection is to selected blood-vessel measures, while routine energy and broader benefits remain less certain.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.44
Customer rating
4.8 · 15,009 ratings
Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 may support selected blood-pressure, lipid or blood-vessel lining measures. The supplied findings come from people with abnormal lipids or endothelial dysfunction, so they do not establish the same benefit for every adult. The disclosed serving receives full preparation-specific amount recognition, without proving prevention of cardiovascular events or a uniquely superior delivery form.

How this product is rated for Cardiovascular Support

Ingredient fit93

Coenzyme Q-10 is the main recognized ingredient; its disclosed serving receives full amount recognition.
Goal fit
The recognized ingredients dominate the formula, with links to other goals reducing its cardiovascular specificity.
Dose adequacy
The disclosed serving receives full amount recognition, which does not establish greater benefit or a personal dose requirement.

Pathways60

The strongest assigned contribution concerns endothelial nitric-oxide function. Other cardiovascular mechanisms have less or no assigned coverage.
Depth
The strongest assigned support concerns endothelial nitric-oxide function, rather than comprehensive cardiovascular protection.
Breadth
Only endothelial nitric-oxide function reaches the coverage threshold.

Evidence88

Coenzyme Q-10 leads the evidence findings. The supplied population and preparation limits remain relevant to expectations.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution; its marker findings do not establish prevention of cardiovascular events.
Studied preparation
The counted preparations are recognized as studied, with the population and exposure distinctions described for the relevant ingredients.

Formulation logic100

The counted ingredients have no unmet partner requirement or identified configured conflict; amount thresholds are considered separately.
Partner coverage
No unmet partner requirement is identified for the counted ingredients; combining them does not establish an added benefit.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All counted ingredients clear the minimum amount threshold, which is distinct from a proven effective dose.
Study evidence
Energy
Impact
High effect
B- Ingredient FitD- PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 participates in cellular energy production and has limited, preparation-specific evidence for fatigue relief. Results from clinical populations do not establish a routine energy boost in healthy adults. The declared preparation and amount matter, without establishing an absorption advantage over other forms.

How this product is rated for Energy

Ingredient fit73

The relevant connection comes from Coenzyme Q-10. The amounts offer different levels of support in the saved findings.
Goal fit
The relevant ingredient is the formulation’s main assessed connection to energy, although it is also linked to other goals.
Dose adequacy
The included amounts receive partial support against the saved amount references, without defining a proven fatigue-treatment dose.

Pathways40

The saved findings concentrate on cellular energy production, without coverage across the other energy pathways.
Depth
Cellular energy production is the best-represented pathway in the saved findings, which does not itself prove fatigue relief.
Breadth
Only one configured pathway reaches the saved coverage requirement; the formulation does not span the other energy pathways.

Evidence95

The strongest included evidence contribution comes from Coenzyme Q-10. Studied-preparation matching does not remove the ingredient-specific limits on fatigue benefits.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence contribution; its population and deficiency limitations still determine the benefit that can be expected.
Studied preparation
The included amounts meet the saved studied-preparation check, without establishing that the finished product itself was tested.

Formulation logic100

The included ingredients meet the saved minimum amount requirement without a missing required partner or matched conflict.
Partner coverage
The included ingredients do not lack a required partner in the saved findings; this does not imply an added combination benefit.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount requirement; this is distinct from a proven effective fatigue-treatment dose.
Study evidence
Heart Health
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 may offer limited support for blood-vessel function and blood pressure, based on small trials in selected populations. This product declares reduced ubiquinol, which has its own exposure comparison. A single serving does not establish the repeated use studied in trials, and these findings do not establish routine prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit93

CoQ10 provides the main recognized connection. The declared amounts meet the saved exposure comparison; this does not establish an effective daily regimen.
Goal fit
CoQ10 is the main recognized focus.
Dose adequacy
The declared amounts meet the saved exposure comparison; this does not establish an effective daily regimen.

Pathways60

The findings center on blood-vessel function, with narrow coverage across the evaluated functions.
Depth
The main recognized connection is blood-vessel function.
Breadth
The breadth finding centers on blood-vessel function, rather than broad coverage of different heart-health functions.

Evidence98

CoQ10 supplies the strongest evidence finding here, based on limited vascular trials in selected populations.
Evidence strength
CoQ10 supplies the strongest evidence finding here, based on limited vascular trials in selected populations.
Studied preparation
The saved preparation check recognizes the counted declarations; this does not establish product-specific trial results.

Formulation logic100

CoQ10 has no identified required-partner gap or configured conflict. All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Partner coverage
No missing required partner was identified among the counted ingredients; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports normal cellular energy production and antioxidant activity. The supplied visible-skin-aging evidence applies to a specific water-soluble preparation, so it offers limited support for expecting the same effects from this form or for extending lifespan.

How this product is rated for Longevity

Ingredient fit73

The counted ingredients are closely focused on the goal's saved findings. The counted amounts provide partial support against the saved targets.
Goal fit
The counted ingredients are closely focused on the goal's saved findings.
Dose adequacy
The counted amounts provide partial support against the saved targets.

Pathways10

The strongest saved coverage concerns cellular energy production.
Depth
The strongest saved coverage concerns cellular energy production.
Breadth
No area reaches the saved threshold for broad coverage.

Evidence30

CoQ10 provides the strongest evidence contribution in the saved findings, which should be understood as support for a limited outcome rather than extended lifespan. CoQ10 does not match the preparation used for the cited skin-aging evidence.
Evidence strength
CoQ10 provides the strongest evidence contribution in the saved findings, which should be understood as support for a limited outcome rather than extended lifespan.
Studied preparation
CoQ10 does not match the preparation used for the cited skin-aging evidence.

Formulation logic100

The counted ingredients meet the saved minimum amounts and have no listed conflict.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
The saved check identified no listed ingredient conflict; this is not a general safety assessment.
Effective doses
1 of 1 counted ingredients meet the saved minimum amount threshold.
Study evidence
Inflammation
Impact
Moderate effect
B- Ingredient FitF PathwaysC EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Ubiquinol is the reduced form of Coenzyme Q-10. Its effect on everyday inflammation remains unclear: the inflammation-related findings for ubiquinone cannot simply be transferred to this form or its amount. Better absorption alone would not tell you whether it reduces inflammation.

How this product is rated for Inflammation

Ingredient fit73

Coenzyme Q-10 provides the connection to inflammation. The amount and relevant form affect how closely the serving matches that role.
Goal fit
Coenzyme Q-10 is the ingredient connecting this serving to inflammation.
Dose adequacy
The selected serving declares Coenzyme Q-10: 100 mg. These amounts are not a daily intake assumption.

Pathways19

The ingredients relate to oxidative stress, which concerns damage associated with reactive molecules. This describes their possible roles, rather than a guarantee of symptom relief.
Depth
The ingredients relate to oxidative stress, which concerns damage associated with reactive molecules. This describes their possible roles, rather than a guarantee of symptom relief.
Breadth
The relevant ingredients concentrate on one type of inflammatory process rather than several distinct mechanisms.

Evidence63

Ubiquinol cannot automatically inherit ubiquinone’s inflammation-related effects.
Evidence strength
Ubiquinol cannot automatically inherit ubiquinone’s inflammation-related effects.
Studied preparation
The declared form cannot inherit an equivalent anti-inflammatory effect from another preparation.

Formulation logic100

No additional partner is required for this ingredient’s individual role, and no particular conflict is identified.
Partner coverage
The relevant ingredients do not require an additional partner for their individual roles.
Conflicts
No particular ingredient conflict is identified in the available facts.
Effective doses
The serving amount of Coenzyme Q-10 can be compared with the ingredient reference; that comparison is not proof of benefit.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 participates in mitochondrial electron transport, helping cells carry out normal energy production. That role and changes in metabolic biomarkers do not establish that supplementation raises whole-body calorie expenditure. The declared amount is therefore a nutritional or mechanistic connection, without a demonstrated routine metabolism boost or preference for a particular form.

How this product is rated for Metabolism Support

Ingredient fit73

Coenzyme Q-10 provide the main connection. The included amounts provide only a partial match to reference exposures; this does not establish effective doses for raising calorie expenditure.
Goal fit
Coenzyme Q-10 provide the main metabolic connection, with little diversion to other ingredients.
Dose adequacy
The included amounts provide only a partial match to reference exposures; this does not establish effective doses for raising calorie expenditure.

Pathways17

The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure. No pathway reached the coverage threshold, so direct support for a metabolism boost remains limited.
Depth
The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure.
Breadth
No pathway reached the coverage threshold, so direct support for a metabolism boost remains limited.

Evidence75

CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Evidence strength
CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Studied preparation
The included preparations match the saved comparison, which does not establish a measured increase in energy expenditure.

Formulation logic100

No missing required partner or configured conflict was identified. The included amounts meet the minimum exposure comparison without demonstrating an extra benefit from combining them.
Partner coverage
No missing required partner was identified; the combination does not establish an additional metabolic-rate effect.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The included ingredients meet the minimum exposure comparison, which does not establish an effective thermogenic or weight-loss dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Ubiquinol (CoQ10)
100 mg 89
Gluten Free Adults 18–50 Dairy Free
Report overview
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value
Each serving provides 100 mg of CoQ10 as ubiquinol. The whole-product serving costs about $0.45.
How this ingredient is rated

Active Ingredient Quality & Bioavailability72

The saved facts identify the CoQ10 as ubiquinol. No specified delivery technology or absorption enhancer is recorded.
Molecular Form: Ubiquinol vs. Ubiquinone
CoQ10 is recorded as ubiquinol, its reduced form.
Formulation & Absorption Enhancers
No liposomal, micellar or nanoemulsion formulation or black pepper extract is recorded in the saved facts.

Dose, Safety & Label Transparency100

A serving provides 100 mg of CoQ10 as ubiquinol. The amount is disclosed, with no flagged additives or standard fillers recorded.
Clinical Dosage Alignment
A serving provides 100 mg of CoQ10 as ubiquinol.
Label Transparency & Fillers
The amount is disclosed, with no flagged additives or standard fillers recorded.

Value100

The whole-product price works out to about $0.45 per 100 mg of CoQ10, a relatively low cost for ubiquinol.
Price Per Effective Serving
The whole-product price works out to about $0.45 per 100 mg of CoQ10, a relatively low cost for ubiquinol.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10